{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Nasonex+Nasal+Spray", "query": { "intervention": "Nasonex Nasal Spray" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 37, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Nasonex+Nasal+Spray&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-26T11:32:43.281Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03463031", "title": "Efficacy and Safety of GSP 301 Nasal Spray in Children (Aged 6 to Under 12 Years) With Seasonal Allergic Rhinitis (SAR)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Seasonal Allergic Rhinitis (SAR)" ], "interventions": [ { "name": "GSP 301 NS", "type": "DRUG" }, { "name": "GSP 301 Placebo NS", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Glenmark Specialty S.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "6 Years to 11 Years" }, "enrollment_count": 446, "start_date": "2018-03-16", "completion_date": "2018-11-14", "has_results": true, "last_update_posted_date": "2019-10-08", "last_synced_at": "2026-09-26T11:32:43.281Z", "location_count": 32, "location_summary": "Mission Viejo, California • Ontario, California • Paramount, California + 26 more", "locations": [ { "city": "Mission Viejo", "state": "California" }, { "city": "Ontario", "state": "California" }, { "city": "Paramount", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT03463031" }, { "nct_id": "NCT02318303", "title": "To Study GSP 301 in Patients With Seasonal Allergic Rhinitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Seasonal Allergic Rhinitis" ], "interventions": [ { "name": "GSP 301-1 NS (QD)", "type": "DRUG" }, { "name": "GSP 301-2 NS (BID)", "type": "DRUG" }, { "name": "GSP 301 Placebo NS", "type": "DRUG" }, { "name": "Olopatadine HCl-1 NS (QD)", "type": "DRUG" }, { "name": "Olopatadine HCl-2 NS (BID)", "type": "DRUG" }, { "name": "Mometasone Furoate-1 NS (QD)", "type": "DRUG" }, { "name": "Mometasone Furoate-2 NS (BID)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Glenmark Pharmaceuticals Ltd. India", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1111, "start_date": "2014-12", "completion_date": "2015-02", "has_results": true, "last_update_posted_date": "2020-10-20", "last_synced_at": "2026-09-26T11:32:43.281Z", "location_count": 10, "location_summary": "Austin, Texas • Kerrville, Texas • New Braunfels, Texas + 2 more", "locations": [ { "city": "Austin", "state": "Texas" }, { "city": "Austin", "state": "Texas" }, { "city": "Austin", "state": "Texas" }, { "city": "Kerrville", "state": "Texas" }, { "city": "New Braunfels", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02318303" }, { "nct_id": "NCT06013241", "title": "A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Rhinosinusitis Without Nasal Polyps" ], "interventions": [ { "name": "Brensocatib", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Mometasone furoate nasal spray (MFNS)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Insmed Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 288, "start_date": "2023-10-30", "completion_date": "2025-10-30", "has_results": false, "last_update_posted_date": "2025-11-10", "last_synced_at": "2026-09-26T11:32:43.281Z", "location_count": 27, "location_summary": "Tucson, Arizona • Roseville, California • Upland, California + 21 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Roseville", "state": "California" }, { "city": "Upland", "state": "California" }, { "city": "Boca Raton", "state": "Florida" }, { "city": "Hollywood", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06013241" }, { "nct_id": "NCT06834360", "title": "A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Rhinosinusitis With Nasal Polyps" ], "interventions": [ { "name": "Itepekimab (SAR440340)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Mometasone furoate nasal spray (MFNS)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 216, "start_date": "2025-02-06", "completion_date": "2027-10-11", "has_results": false, "last_update_posted_date": "2026-06-02", "last_synced_at": "2026-09-26T11:32:43.281Z", "location_count": 15, "location_summary": "Birmingham, Alabama • La Mesa, California • Los Angeles, California + 12 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "La Mesa", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Napa", "state": "California" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06834360" }, { "nct_id": "NCT03705793", "title": "Effectiveness of Mometasone Nasal Irrigation for Chronic Rhinosinusitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Rhinosinusitis (Diagnosis)", "Allergic Rhinosinusitis", "Chronic Eosinophilic Rhinosinusitis" ], "interventions": [ { "name": "Mometasone Furoate Nasal Irrigation", "type": "DRUG" }, { "name": "Mometasone Nasal Spray", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 53, "start_date": "2019-01-01", "completion_date": "2020-03-15", "has_results": true, "last_update_posted_date": "2025-06-26", "last_synced_at": "2026-09-26T11:32:43.281Z", "location_count": 2, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03705793" }, { "nct_id": "NCT06691113", "title": "A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Rhinosinusitis Without Nasal Polyps" ], "interventions": [ { "name": "Itepekimab (SAR440340)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Mometasone furoate nasal spray (MFNS)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 66, "start_date": "2024-12-16", "completion_date": "2026-08-12", "has_results": false, "last_update_posted_date": "2026-08-25", "last_synced_at": "2026-09-26T11:32:43.281Z", "location_count": 10, "location_summary": "Birmingham, Alabama • La Jolla, California • Murrieta, California + 7 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "La Jolla", "state": "California" }, { "city": "Murrieta", "state": "California" }, { "city": "Roseville", "state": "California" }, { "city": "Wheat Ridge", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT06691113" }, { "nct_id": "NCT00361439", "title": "Treatment of Olfactory Dysfunction in Seasonal Allergic Rhinitis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Seasonal Allergic Rhinitis" ], "interventions": [ { "name": "Mometasone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "59 Years", "sex": "ALL", "summary": "18 Years to 59 Years" }, "enrollment_count": 17, "start_date": "2006-08", "completion_date": "2008-09", "has_results": true, "last_update_posted_date": "2014-02-28", "last_synced_at": "2026-09-26T11:32:43.281Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00361439" }, { "nct_id": "NCT01287364", "title": "Evaluation of a Novel Questionnaire to Assess Patient Satisfaction With and Preference of Intranasal Corticosteroids for the Treatment of Allergic Rhinitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Perennial Allergic Rhinitis" ], "interventions": [ { "name": "ciclesonide hydrofluoroalkane (HFA) nasal aerosol", "type": "DRUG" }, { "name": "mometasone nasal inhalation", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 185, "start_date": "2011-02", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2012-11-02", "last_synced_at": "2026-09-26T11:32:43.281Z", "location_count": 6, "location_summary": "Mission Viejo, California • San Diego, California • North Dartmouth, Massachusetts + 3 more", "locations": [ { "city": "Mission Viejo", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "North Dartmouth", "state": "Massachusetts" }, { "city": "Minneappolis", "state": "Minnesota" }, { "city": "Skillman", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT01287364" }, { "nct_id": "NCT01732536", "title": "Steroid-Releasing S8 Sinus Implant for Recurrent Nasal Polyps", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Chronic Sinusitis", "Nasal Polyps" ], "interventions": [ { "name": "S8 Sinus Implant", "type": "DRUG" }, { "name": "Sham procedure", "type": "PROCEDURE" }, { "name": "Mometasone furoate nasal spray", "type": "DRUG" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Intersect ENT", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 100, "start_date": "2013-01", "completion_date": "2014-05", "has_results": true, "last_update_posted_date": "2018-07-20", "last_synced_at": "2026-09-26T11:32:43.281Z", "location_count": 19, "location_summary": "Atherton, California • Los Angeles, California • Sacramento, California + 16 more", "locations": [ { "city": "Atherton", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01732536" }, { "nct_id": "NCT00618332", "title": "Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis?", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Seasonal Allergic Rhinitis" ], "interventions": [ { "name": "mometasone furoate nasal spray", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 40, "start_date": "2008-04", "completion_date": "2010-07", "has_results": true, "last_update_posted_date": "2014-02-14", "last_synced_at": "2026-09-26T11:32:43.281Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00618332" } ] }